NasdaqGS - Delayed Quote • USD
DENTSPLY SIRONA Inc. (XRAY)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:41 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 16 | 15 |
| Avg. Estimate | 0.42 | 0.54 | 2.06 | 2.41 |
| Low Estimate | 0.4 | 0.51 | 2.03 | 2.27 |
| High Estimate | 0.46 | 0.57 | 2.1 | 2.6 |
| Year Ago EPS | 0.39 | 0.51 | 1.83 | 2.06 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 15 |
| Avg. Estimate | 969.14M | 1.02B | 3.99B | 4.15B |
| Low Estimate | 958.48M | 1.01B | 3.98B | 4.09B |
| High Estimate | 982.69M | 1.04B | 4.02B | 4.21B |
| Year Ago Sales | 978M | 1.03B | 3.96B | 3.99B |
| Sales Growth (year/est) | -0.90% | -0.50% | 0.70% | 3.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.34 | 0.43 | 0.48 | 0.43 |
| EPS Actual | 0.39 | 0.51 | 0.49 | 0.44 |
| Difference | 0.05 | 0.08 | 0.01 | 0.01 |
| Surprise % | 14.70% | 18.60% | 2.10% | 2.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.42 | 0.54 | 2.06 | 2.41 |
| 7 Days Ago | 0.42 | 0.54 | 2.06 | 2.41 |
| 30 Days Ago | 0.42 | 0.54 | 2.06 | 2.41 |
| 60 Days Ago | 0.46 | 0.54 | 2.05 | 2.43 |
| 90 Days Ago | 0.46 | 0.54 | 2.05 | 2.43 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | -- |
| Up Last 30 Days | 1 | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
| CURRENCY IN USD | XRAY | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 7.70% | -- | -- | 1.60% |
| Next Qtr. | 5.90% | -- | -- | 10.50% |
| Current Year | 12.60% | -- | -- | 5.20% |
| Next Year | 17.00% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 14.10% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -5.59% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Barrington Research: Outperform to Outperform | 4/18/2024 |
| Reiterates | Barrington Research: Outperform to Outperform | 3/1/2024 |
| Reiterates | Needham: Buy to Buy | 2/29/2024 |
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 1/12/2024 |
| Maintains | Needham: Buy to Buy | 1/9/2024 |
Related Tickers
NVST Envista Holdings Corporation
19.96
+1.06%
UTMD Utah Medical Products, Inc.
68.58
+2.01%
TFX Teleflex Incorporated
206.56
-0.40%
ATRI Atrion Corporation
402.35
+4.32%
COO The Cooper Companies, Inc.
90.42
+0.01%
AZTA Azenta, Inc.
50.65
+0.32%
ANIK Anika Therapeutics, Inc.
25.84
+1.61%
ICUI ICU Medical, Inc.
95.77
-1.17%
HOLX Hologic, Inc.
75.38
+0.37%
ANGO AngioDynamics, Inc.
6.26
+2.29%